Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brexpiprazole S-oxide D8 (DM-3411 D8) is a deuterium labeled Brexpiprazole S-oxide. Brexpiprazole S-oxide is a main metabolite of Brexpiprazole. Brexpiprazole is a partial agonist of human 5-HT1A and dopamine receptors (Kis: 0.12 nM and 0.3 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Brexpiprazole S-oxide D8 (DM-3411 D8) is a deuterium labeled Brexpiprazole S-oxide. Brexpiprazole S-oxide is a main metabolite of Brexpiprazole. Brexpiprazole is a partial agonist of human 5-HT1A and dopamine receptors (Kis: 0.12 nM and 0.3 nM). |
Targets&IC50 | 5-HT1A:ki: 0.12 nM , 5-HT2A(ki):0.47 nM (ki), D2L:0.3 nM (ki) |
Synonyms | DM-3411 D8 |
Molecular Weight | 457.61 |
Formula | C25H19D8N3O3S |
CAS No. | 2748605-29-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brexpiprazole S-oxide D8 2748605-29-8 GPCR/G Protein Neuroscience 5-HT Receptor Dopamine Receptor DM-3411 D8 Brexpiprazole S-oxide D-8 Brexpiprazole S oxide D8 Brexpiprazole Soxide D8 inhibitor inhibit